These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer? Kranzler HR; Kadden RM; Burleson JA; Babor TF; Apter A; Rounsaville BJ Compr Psychiatry; 1995; 36(4):278-88. PubMed ID: 7554872 [TBL] [Abstract][Full Text] [Related]
7. Anxiety and addiction: a clinical perspective on comorbidity. DuPont RL Bull Menninger Clin; 1995; 59(2 Suppl A):A53-72. PubMed ID: 7795572 [TBL] [Abstract][Full Text] [Related]
8. A pilot test of motivational interviewing groups for dually diagnosed inpatients. Van Horn DH; Bux DA J Subst Abuse Treat; 2001 Mar; 20(2):191-5. PubMed ID: 11306222 [TBL] [Abstract][Full Text] [Related]
9. Dual diagnosis in Spain. Gual A Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838 [TBL] [Abstract][Full Text] [Related]
10. Predicting compliance of dual diagnosis inpatients with aftercare treatment. Wolpe PR; Gorton G; Serota R; Sanford B Hosp Community Psychiatry; 1993 Jan; 44(1):45-9. PubMed ID: 8382186 [TBL] [Abstract][Full Text] [Related]
11. Anxiety and psychoactive substance use disorder comorbidity in anorexia nervosa or depression. Jordan J; Joyce PR; Carter FA; Horn J; McIntosh VV; Luty SE; McKenzie JM; Mulder RT; Bulik CM Int J Eat Disord; 2003 Sep; 34(2):211-9. PubMed ID: 12898557 [TBL] [Abstract][Full Text] [Related]
12. Understanding and treating comorbid anxiety disorders in substance users: review and future directions. Wolitzky-Taylor K; Operskalski JT; Ries R; Craske MG; Roy-Byrne P J Addict Med; 2011 Dec; 5(4):233-47. PubMed ID: 22042216 [TBL] [Abstract][Full Text] [Related]
13. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic. Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330 [TBL] [Abstract][Full Text] [Related]
14. Dimensional characteristics of the SCL-90-R: evaluation of gender differences in dually diagnosed inpatients. Carpenter KM; Hittner JB J Clin Psychol; 1995 May; 51(3):383-90. PubMed ID: 7560139 [TBL] [Abstract][Full Text] [Related]
15. Treatment contracts for patients with hepatitis C, psychiatric illness, and substance abuse. Gallucci G; Smolinski J Psychosomatics; 2001; 42(4):353-5. PubMed ID: 11496027 [No Abstract] [Full Text] [Related]
18. [Depression and anxiety]. Kasper S; Pezawas L Wien Med Wochenschr; 1999; 149(18):494-502. PubMed ID: 10637953 [TBL] [Abstract][Full Text] [Related]
19. A psychotherapeutic approach to substance abuse: preliminary observations. Silvers EP Am J Drug Alcohol Abuse; 1993; 19(1):51-64. PubMed ID: 8438831 [TBL] [Abstract][Full Text] [Related]
20. [Psychotropic drugs outside of psychiatry, especially in advanced age]. Barolin GS Wien Med Wochenschr; 1993; 143(9):236-44. PubMed ID: 8351936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]